Vivoryon Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?

4.4yrs

Average management tenure


CEO

Ulrich Dauer (57 yo)

4.42yrs

Tenure

€530,096

Compensation

Dr. Ulrich Dauer has been Chief Executive Officer and Chairman of the Management Board at Vivoryon Therapeutics N.V. (formerly known as Vivoryon Therapeutics AG) since May 01, 2018. He has been Chairman of...


CEO Compensation Analysis

Ulrich Dauer's Compensation vs Vivoryon Therapeutics Earnings
How has Ulrich Dauer's remuneration changed compared to Vivoryon Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Jun 30 2022n/an/a

-€14m

Mar 31 2022n/an/a

-€13m

Dec 31 2021n/an/a

-€13m

Sep 30 2021n/an/a

-€12m

Jun 30 2021n/an/a

-€21m

Mar 31 2021n/an/a

-€19m

Dec 31 2020n/an/a

-€17m

Sep 30 2020n/an/a

-€15m

Jun 30 2020n/an/a

-€12m

Mar 31 2020n/an/a

-€10m

Dec 31 2019€530k€240k

-€8m

Sep 30 2019n/an/a

-€7m

Jun 30 2019n/an/a

-€7m

Mar 31 2019n/an/a

-€7m

Dec 31 2018€163k€160k

-€8m

Compensation vs Market: Insufficient data to establish whether Ulrich's total compensation is reasonable compared to companies of similar size in the Dutch market.

Compensation vs Earnings: Ulrich's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: VVY's management team is considered experienced (4.4 years average tenure).